<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nine Italian and 12 German children fulfilled the criteria of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), according to the French-American-British (FAB) classification </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients belonged to the more aggressive subtypes of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Four presented with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), 16 presented with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>), and 1 had <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Dyserythropoiesis and dysgranulopoiesis were seen in <z:hpo ids='HP_0000001'>all</z:hpo> patients, and dysmegakaryopoiesis was seen in most patients </plain></SENT>
<SENT sid="4" pm="."><plain>Cytogenetic studies in 13 of the 21 children showed karyotype abnormalities in 8; 5 had <z:mp ids='MP_0004026'>monosomy</z:mp> 7 </plain></SENT>
<SENT sid="5" pm="."><plain>Eleven patients were treated with intensive chemotherapy soon after diagnosis; 6 achieved complete remission (CR), and 2 of them are alive and still in complete remission after 48 and 69 months </plain></SENT>
<SENT sid="6" pm="."><plain>Low-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (Ara-C) was given in six children without improvement </plain></SENT>
<SENT sid="7" pm="."><plain>Bone marrow transplantation after progression of the disease has produced complete remission lasting 28 + months now in one of two patients </plain></SENT>
<SENT sid="8" pm="."><plain>Four patients received only symptomatic treatment </plain></SENT>
<SENT sid="9" pm="."><plain>The rate of 5-year survival for the total group was 20% (SD 9%) </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may benefit from more aggressive treatment, but that in general the survival rate is poor and similar to that observed in adults with the same subtypes of this disease </plain></SENT>
</text></document>